# FDA Inspection 1170761 - Boehringer Ingelheim RCV GmbH & Co KG - January 28, 2021

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/ae313532-f368-41d2-b5af-f45e1c117cd7
Source feed: FDA_Inspections

> FDA Inspection 1170761 for Boehringer Ingelheim RCV GmbH & Co KG on January 28, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1170761
- Company Name: Boehringer Ingelheim RCV GmbH & Co KG
- Inspection Date: 2021-01-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1258048 - 2024-11-12](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/16b950bf-59de-4188-9b07-5e884ebdfe91)
- [FDA Inspection 1258048 - 2024-11-12](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/5629f2fe-63c9-4137-bda3-e90b8505a984)
- [FDA Inspection 1226783 - 2023-12-05](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/58b1a87d-a90e-4ba5-b7e5-ec998156c23b)
- [FDA Inspection 1223893 - 2023-11-16](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/5b9ef9a3-8f71-4fda-8534-f0f594c7979e)
- [FDA Inspection 1210971 - 2023-03-02](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/3cfa7c2f-3876-4a03-8a8f-2b34332d7f2c)

Company: https://www.keypedia.com/companies/boehringer-ingelheim-rcv-gmbh-co-kg/44a0d48b-1c34-490c-87fe-ccfec769342f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c